Inventor · disambiguated record
Amanda Jane Van De Poël
Also filed as: VAN DE POËL AMANDA J · VAN DE POËL AMANDA JANE · Van de Poël Amanda
19 granted patents·4 pending applications·130 citations·filing 2015–2024
95Inventor score
Top patents by PatentIndex Score
23 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0797US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 0897US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 0997US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1097US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1197US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1297US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1397US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1497US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1597US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1691US2024336582A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1787US2023250071A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1885US11806346B2HTT modulators for treating Huntington's diseaseCHDI FOUNDATION INC·Filed 2021·Granted Nov 7, 2023·1 cites·37 claims
- 1970US10053434B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted Aug 21, 2018·1 cites·36 claims
- 2070US10047073B2Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted Aug 14, 2018·1 cites·30 claims
- 2153US11685734B2ATM kinase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2020·Granted Jun 27, 2023·0 cites·35 claims
- 2249US2019185463A1Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Application pending·0 cites
- 2349US2019202795A1Histone deacetylase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amanda Jane Van De Poël files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →